Otrivin Menthol (Xylometazoline Hydrochloride)

Xylometazoline hydrochloride, the active ingredient in Otrivin Menthol, is an alpha‑adrenergic agonist presented as a nasal spray for topical intranasal use. It relieves nasal congestion associated with common colds, sinusitis, and allergic rhinitis in adults and children.

GNH USA supplies Otrivin Menthol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Otrivin Menthol, a topical nasal decongestant, acts on the nasal mucosa to reduce swelling and improve airflow.

- Common cold: temporary relief of nasal congestion. - Sinusitis: helps clear blocked nasal passages. - Allergic rhinitis: eases congestion caused by allergens. - Upper respiratory tract infection: supports better breathing during infection.

Adverse reactions are generally mild and related to local irritation of the nasal mucosa.

Common Side Effects: - Burning sensation: mild burning or stinging in the nose. - Nasal dryness: reduced moisture leading to a dry feeling. - Sneezing: transient episodes after application. - Headache: mild headache in some users. - Epistaxis: occasional minor nosebleeds.

Serious or Rare Side Effects: - Rebound congestion: worsening nasal blockage after prolonged use. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Persistent nasal irritation: ongoing redness or ulceration. - Hypertension exacerbation: increased blood pressure in susceptible individuals.

When using Otrivin Menthol, consider the following safety measures:

- Age restriction: use only   - Contra‑indication:   "); -  ");   "  "  " ""  " "" " "  ""  "" "  "" " " " "" " " " "" "" "" "  " "" " " " " " " " " " " "" ". -  ");  \